Pascale Diesel and Lev Gerlovin, both vice presidents at Charles River Associates (CRA), describe the current capabilities and future potential of bioprinting alongside Andrew Thomson, an analyst in the life sciences practice at CRA. Read more

, , News

Russian companies Roscosmos and Invitro-owned 3D Bioprinting Solutions have seen their technology bioprint human tissue in space. Read more


Poietis, billed as the first 4D bioprinting company, has announced the commercialisation of its new range of Next Generation Bioprinting systems (NGB). Read more


Droplet dispensing concept could enable high-speed, high-density, multi-colour printing for diagnostics, tissue engineering and drug discovery. Read more